Stock Research for BCLI

Current Price


Latest Update: 2018-03-16 16:00:00

$ 3.5300
$ 3.4500
$ 3.4500

Featured Broker: TradeStation

Get the due diligence for another stock.


BCLI Stock Chart & Research Data

The BCLI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BCLI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


BCLI Due diligence Resources & Stock Charts

The BCLI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BCLI Detailed Price Forecast - CNN Money CNN View BCLI Detailed Summary - Google Finance
Yahoo View BCLI Detailed Summary - Yahoo! Finance Zacks View BCLI Stock Research & Analysis -

Stock Analysis

TradeIdeas View BCLI Trends & Analysis - Trade-Ideas Barrons View BCLI Major Holders - Barrons
NASDAQ View BCLI Call Transcripts - NASDAQ Seeking View BCLI Breaking News & Analysis - Seeking Alpha
Spotlight View BCLI Annual Report - OTC Report View BCLI OTC Short Report -
TradeKing View BCLI Fundamentals - TradeKing Charts View BCLI SEC Filings - Bar Chart
WSJ View Historical Prices for BCLI - The WSJ Morningstar View Performance/Total Return for BCLI - Morningstar
MarketWatch View the Analyst Estimates for BCLI - MarketWatch CNBC View the Earnings History for BCLI - CNBC
StockMarketWatch View the BCLI Earnings - StockMarketWatch MacroAxis View BCLI Buy or Sell Recommendations - MacroAxis
Bullish View the BCLI Bullish Patterns - American Bulls Short Pains View BCLI Short Pain Metrics -

Social Media Mentions

StockTwits View BCLI Stock Mentions - StockTwits PennyStocks View BCLI Stock Mentions - PennyStockTweets
Twitter View BCLI Stock Mentions - Twitter Invest Hub View BCLI Investment Forum News - Investor Hub
Yahoo View BCLI Stock Mentions - Yahoo! Message Board Seeking Alpha View BCLI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for BCLI - Insider Cow View Insider Transactions for BCLI - Insider Cow
CNBC View BCLI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BCLI - OTC Markets
Yahoo View Insider Transactions for BCLI - Yahoo! Finance NASDAQ View Institutional Holdings for BCLI - NASDAQ

Stock Charts

FinViz View BCLI Stock Insight & Charts - StockCharts View BCLI Investment Charts -
BarChart View BCLI Stock Overview & Charts - BarChart Trading View View BCLI User Generated Charts - Trading View

Latest Financial News for BCLI

BrainStorm Cell Therapeutics to Present at the BIO Asia International Conference and the Wall Street Investor Forum
Posted on Thursday March 15, 2018

HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 15, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...

BCLI: Phase 3 Trial in ALS Enrolling Patients
Posted on Tuesday March 13, 2018

BrainStorm Cell Therapeutics, Inc. (BCLI) has enrolled the first patients in the Phase 3 clinical trial of NurOwn® (NCT03280056) for the treatment of amyotrophic lateral sclerosis (ALS). Cells will be extracted from each patient one time prior to treatment, with all administrations of NurOwn® derived from the same extraction of cells thanks to a cryopreservation process developed for long-term storage of mesenchymal stem cells (MSC). The company is focusing the trial on faster-progressing ALS patients since these patients demonstrated superior outcomes in the Phase 2 trial of NurOwn®.

Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer
Posted on Tuesday March 13, 2018

Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the development ...

BrainStorm Announces Formation of Scientific Advisory Board and Appoints Neuroscientist Jerold Chun, M.D., Ph.D., to Chair
Posted on Sunday March 11, 2018

HACKENSACK, N.J. and PETACH TIKVAH, Israel, March 12, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today the formation of its Scientific Advisory Board (SAB) and the appointment of Jerold Chun, M.D., Ph.D., to Chair. Chun is an acclaimed neuroscientist and professor at Sanford Burnham Prebys Medical Discovery Institute with decades of expertise in degenerative disease research and neuroscience drug development. The SAB at BrainStorm will be composed of renowned scientists and clinical experts and will advise BrainStorm's management team on scientific matters such as research, clinical trials and drug development.

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.